In agreement with our results, the IL-1RN *2 genotype has been proposed to be associated with reduced breast cancer prevalence, and the IL1RN 2 allele was found to decrease the risk of breast cancer with a borderline significance 18 .
← all excerpts
Association between the Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Lymphoma.
1
—
—